ORAL PRESENTATIONSThursday, March 31Parallel Session: HCV THERAPY9 BOCEPREVIR RESISTANCE-ASSOCIATED VARIANTS (RAVS) ARE OBSERVED MORE FREQUENTLY IN HCV (GT1)-INFECTED PATIENTS WITH POOR RESPONSE TO PEGINTERFERON ALFA-2B/RIBAVIRIN
Thursday, March 31
Parallel Session: HCV THERAPY
References (0)
Cited by (0)
Copyright © 2011 Elsevier Ltd. All rights reserved.